|
answer text |
<p>The Government is working to better understand the impacts the operation of the
current Voluntary Scheme on investments in the UK and access to medicines. We are
therefore in direct conversations with companies to understand these impacts. The
Department for Business, Energy and Industrial Strategy is in close discussions with
the Department of Health and Social Care, the Department responsible for the Voluntary
Scheme, about the business environment for life sciences and its impact on investment
and patient access.</p>
|
|